A ruthenium(II) N-heterocyclic carbene (NHC) complex with naphthalimide ligand triggers apoptosis in colorectal cancer cells via activating the ROS-p38 MAPK pathway

• Verfasst von: Dabiri, Yasamin [VerfasserIn]
• Verfasst von: Schmid, Alice [VerfasserIn]
• Verfasst von: Theobald, Jannick [VerfasserIn]
• Verfasst von: Blagojević, Biljana [VerfasserIn]
• Verfasst von: Wölfl, Stefan [VerfasserIn]
• Verfasst von: Cheng, Xinlai [VerfasserIn]
• Titel: A ruthenium(II) N-heterocyclic carbene (NHC) complex with naphthalimide ligand triggers apoptosis in colorectal cancer cells via activating the ROS-p38 MAPK pathway
• Verf.angabe: Yasamin Dabiri, Alice Schmid, Jannick Theobald, Biljana Blagojevic, Wojciech Streciwilk, Ingo Ott, Stefan Wölfl and Xinlai Cheng
• E-Jahr: 2018
• Jahr: 9 December 2018
• Umfang: 20 S.
• Fussnoten: Gesehen am 03.01.2019
• Titel Quelle: Enthalten in: International journal of molecular sciences
• Ort Quelle: Basel : Molecular Diversity Preservation International, 2000
• Jahr Quelle: 2018
• Band/Heft Quelle: 19(2018,12) Artikel-Nummer 3964, 20 Seiten
• ISSN Quelle: 1422-0067
• ISSN Quelle: 1661-6596
• DOI: doi:10.3390/ijms19123964
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: <i>N</i>-heterocyclic carbene
• Sach-SW: apoptosis
• Sach-SW: cancer
• Sach-SW: mitochondria
• Sach-SW: naphthalimide-metal complex conjugates
• Sach-SW: p38 MAPK
• Sach-SW: ROS
• K10plus-PPN: 1585909440
• K10plus-PPN:
  Universitätsbibliothek
• Lokale URL UB: Zum Volltext

Abstract

The p38 MAPK pathway is known to influence the anti-tumor effects of several chemotherapeutics, including that of organometallic drugs. Previous studies have demonstrated the important role of p38 both as a regulator and a sensor of cellular reactive oxygen species (ROS) levels. Investigating the anti-cancer properties of novel 1,8-naphthalimide derivatives containing Rh(I) and Ru(II) N-heterocyclic carbene (NHC) ligands, we observed a profound induction of ROS by the complexes, which is most likely generated from mitochondria (mtROS). Further analyses revealed a rapid and consistent activation of p38 signaling by the naphthalimide-NHC conjugates, with the Ru(II) analogue - termed MC6 - showing the strongest effect. In view of this, genetic as well as pharmacological inhibition of p38&alpha;, attenuated the anti-proliferative and pro-apoptotic effects of MC6 in HCT116 colon cancer cells, highlighting the involvement of this signaling molecule in the compound's toxicity. Furthermore, the influence of MC6 on p38 signaling appeared to be dependent on ROS levels as treatment with general- and mitochondria-targeted anti-oxidants abrogated p38 activation in response to MC6 as well as the molecule's cytotoxic- and apoptogenic response in HCT116 cells. Altogether, our results provide new insight into the molecular mechanisms of naphthalimide-metal NHC analogues via the ROS-induced activation of p38 MAPK, which may have therapeutic interest for the treatment of various cancer types.